350 rub
Journal Technologies of Living Systems №8 for 2012 г.
Article in number:
Uptake of sulfonated aluminium phtalocyanine and protoporphyrin-IX induced from 5-ala in atherosclerotic rabbit aortas
Authors:
Yu.E. Efremova, G.N. Soboleva, E.R. Andreeva, N.V. Radukhina, S.G. Kuzmin, Yu.A. Karpov, E.M. Tararak
Abstract:
Photodynamic therapy is a method that is widely applied in clinical practice since the middle of last century, mainly for the treatment of oncology diseases. This approach is based on the fact that certain cells have the capacity to accumulate photosensitizes (PS). When illuminated with appropriate wave length light these PS are produced reactive oxygen resulting in cell death. Several studies have shown that photosensitizers accumulated within atherosclerotic lesions. The results of these studies suggest that photodynamic may be promising tool in the diagnosis and treatment of atherosclerosis. The aim of this study was to reveal Photosens (sulfonated aluminium phthalocyanine) and Alasens (5-aminolevulinic acid) uptake in atherosclerotic rabbit aortas and immunohistochemical identification of cell types that had accumulated photosensitizers. In our work 25 rabbits were studied. 11 rabbits with experimental atherosclerosis were injected Photosens, 8 - Alasens, 6 animals were taken as a controls. After the killing of animals histological, immunohistochemical and fluorescence analysis of the aorta was performed. Fluorescence analysis showed photosensitizers accumulation in all arteriosclerotic lesions. In contrast, the fluorescence of the photosensitizers was not detected in normal vascular wall. The preferential uptake of photosensitizers was detected in the atherosclerotic intima. The level of PS accumulation was depended on the degree of lesions. Highly cellular plaque segments (most often plaque-s shoulders and superficial layer of plaque) showed markedly increased fluorescence intensity. Fluorescence intensity of photosensitizers was positively correlated with macrophage content in advanced atherosclerotic lesions. In none of the control animals the fluorescence of photosensitizers was identified. In most cases are the causes of serious cardiovascular events the unstable atherosclerotic plaques. These lesions contain large amount of inflammatory cells, particularly macrophages. A pivotal goal of photodynamic therapy in promoting plaque stabilization is sustained macrophage removal. Our data on photosensitizers accumulation in atherosclerotic plaque areas with a large number of macrophages suggest that the photodynamic reaction is promising tool for the diagnosis and treatment of unstable plaque.
Pages: 31-38
References
  1. Гельфонд М.Л. Фотодинамическая терапия в онкологии // Практическая онкология. 2007. Т. 8. № 4. С. 204-210.
  2. Castano A.P., Demidova T.N. and Hamblin M.R. Mechanisms in photodynamic therapy: part one - photosensitizers, photochemistry and cellular localization // Photodiag. Photodynam. Ther. 2004. V. 1. P. 279-293.
  3. Yamaguchi S., Tsuda H., Takemori M., et al. Photodynamic therapy for cervical intraepithelial neoplasia // Oncology. 2005. V. 69. P. 110-116.
  4. Delettre E., Brault D., Bruneval P., et al. In vitro uptake of dicarboxylic porphyrins by human atheroma. Kinetic and analytical studies// Photochemistry and Photobiology. 1991. V. 54 (2).
    P. 239-246.
  5. Gonschior P., Erdemci A., Gerheuser F., et al. Fluorescence microscopic and histologic analysis of photosensitizer uptake in human atherosclerotic lesions // Lasers in Medical Science. 1993. V. 8. P. 289-295.
  6. Pollock M.E., Eugene J., Hammer-Wilson M., Berns M.W. Photosensitization of Experimental Atheromas by Porphyrins // J. Am. Coll. Cardiol. 1987. V. 9. P. 639-646.
  7. Kwon O.C., Yoon H.J., Kim K.H., et al. Fluorescence Kinetics of Protoporphyrin-IX Induced from 5-ALA. Compounds in Rabbit Postballoon Injury Model for ALA-Photoangioplasty //
    Photochemistry and Photobiology. 2008. V. 84. P. 1209-1214.
  8. Allison B.A., Crespo M.T., Jain A.K., et al. Delivery of benzoporphyrin derivative, a photosensitizer, into atherosclerotic plaque of Watanabe heritable hyperlipidemic rabbits and balloon-injured New Zealand rabbits // Photochemistry and Photobiology. 1997. V. 65 (5). P. 877-883.
  9. Spears J.R., Serur J., Shropshire D., Paulin S. Fluorescence of experimental atheromatous plaques with hematoporphyrin derivative // J. Clin. Invest. 1983. V. 71 (2). P. 395-399.
  10. Eldar M., Yerushalmi Y., Kessler E., et. al. Preferential uptake of a water-soluble phthalocyanine by atherosclerotic plaques in rabbits // Atherosclerosis. 1990. V. 84 (2-3). P. 135-139.
  11. Katoh T., Asahara T., Naitoh Y., et. al. In vivo intravascular laser photodynamic therapy in rabbit atherosclerotic lesions using a lateral direction fiber // Lasers. Surg. Med. 1997. V. 20 (4). P. 373-381.
  12. Biały D., Derkacz A., Wawrzynska M., et. al. In vitro photodynamic diagnosis of atherosclerotic wall changes with the use of mono-l-aspartyl chlorin e6 // Polish Heart Journal. 2003. V. 59. P. 298-301.
  13. Hsiang Y.N., Crespo M.T., Richter A.M., et. al. In vitro and in vivo uptake of benzoporphyrin derivative into human and miniswine atherosclerotic plaque // Photochemistry and Photobiology. 1993. V. 57(4). P. 670-674.
  14. Spokojny A.M., Serur J.R., Skillman J., Spears J.R. Uptake of hematoporphyrin derivative by atheromatous plaques: studies in human in vitro and rabbit in vivo // J. Am. Coll. Cardiol. 1986. V. 8. P. 1387-1392.
  15. Андреева Е.Р., Ударцева О.О., Возовиков И.Н.
    и др
    . Изучение in vitro фотодинамического воздействия на возможные клетки-мишени сосудистой стенки// Кардиологический вестник. 2008. № 2. С. 12-16.
  16. Hayase M., Woodbum K.W., Perlroth J., et. al.Photoangioplasty with local motexafin lutetium delivery reduces macrophages in a rabbit post-balloon injury model // Cardiovasc. Res. 2001. V. 49 (2). P. 449-455.
  17. Waksman R., McEwan P.E., Moore T.I., et. al. PhotoPoint Photodynamic Therapy Promotes Stabilization of Atherosclerotic Plaques and Inhibits Plaque Progression // J. Am. Coll. Cardiol. 2008. V. 52. P. 1024-1032.
  18. Peng C., Li Y., Liang H., et. al. Detection and photodynamic therapy of inflamed atherosclerotic plaques in the carotid artery of rabbits // Journal of Photochemistry and Photobiology. 2011. V.102. Р. 26-31.
  19. Davies M.J., Richardson P.D., Woolf N., et. al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content // Br. Heart J. 1993. V. 69. P. 377-381.
  20. Van Der Wal A.C., Becker A.E., Van Der Loos C.M., Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology // Circulation. 1994. V. 89. P. 36-44.
  21. Moreno P.R., Falk E., Palacios I.F., et. al. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture // Circulation. 1994. V. 90. P. 775-778.
  22. Virmani R., Kolodgie F.D., Burke A.P., et. al. Lesson from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions // Arterioscler. Thromb. Vasc. Biol. 2000. V. 20. P. 1262-1275.
  23. Takashi K., Takeya M., and Sakashita N. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals // Med. Electron. Microsc. 2002. V. 35. P. 179-203.